[go: up one dir, main page]

CO2019011592A2 - Proceso para la fabricación de la forma alfa de vortioxetina hbr - Google Patents

Proceso para la fabricación de la forma alfa de vortioxetina hbr

Info

Publication number
CO2019011592A2
CO2019011592A2 CO2019011592A CO2019011592A CO2019011592A2 CO 2019011592 A2 CO2019011592 A2 CO 2019011592A2 CO 2019011592 A CO2019011592 A CO 2019011592A CO 2019011592 A CO2019011592 A CO 2019011592A CO 2019011592 A2 CO2019011592 A2 CO 2019011592A2
Authority
CO
Colombia
Prior art keywords
manufacture
alpha form
vortioxetine hbr
vortioxetine
hbr
Prior art date
Application number
CO2019011592A
Other languages
English (en)
Inventor
Hans Petersen
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=62111030&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO2019011592(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H Lundbeck As filed Critical H Lundbeck As
Publication of CO2019011592A2 publication Critical patent/CO2019011592A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

RESUMEN Se proporciona un proceso para la fabricación de la forma α de vortioxetina HBr.
CO2019011592A 2017-04-25 2019-10-18 Proceso para la fabricación de la forma alfa de vortioxetina hbr CO2019011592A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201700264 2017-04-25
PCT/EP2018/060192 WO2018197360A1 (en) 2017-04-25 2018-04-20 Process for the manufacture of vortioxetine hbr alpha-form

Publications (1)

Publication Number Publication Date
CO2019011592A2 true CO2019011592A2 (es) 2019-10-31

Family

ID=62111030

Family Applications (1)

Application Number Title Priority Date Filing Date
CO2019011592A CO2019011592A2 (es) 2017-04-25 2019-10-18 Proceso para la fabricación de la forma alfa de vortioxetina hbr

Country Status (27)

Country Link
US (1) US11124491B2 (es)
EP (1) EP3615518B1 (es)
JP (1) JP7121751B2 (es)
KR (1) KR102551433B1 (es)
CN (1) CN110520415A (es)
AU (1) AU2018258947C1 (es)
BR (1) BR112018076411A2 (es)
CA (1) CA3059515A1 (es)
CL (1) CL2019003024A1 (es)
CO (1) CO2019011592A2 (es)
CY (1) CY1124974T1 (es)
DK (1) DK3615518T3 (es)
ES (1) ES2905962T3 (es)
HR (1) HRP20220108T1 (es)
HU (1) HUE057993T2 (es)
IL (1) IL270052B2 (es)
LT (1) LT3615518T (es)
MA (1) MA49056A (es)
MX (1) MX2019012765A (es)
PL (1) PL3615518T3 (es)
PT (1) PT3615518T (es)
RS (1) RS62823B1 (es)
SG (1) SG11201909678PA (es)
SI (1) SI3615518T1 (es)
SM (1) SMT202200073T1 (es)
WO (1) WO2018197360A1 (es)
ZA (1) ZA201906829B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3762371A1 (en) * 2018-02-06 2021-01-13 Piramal Enterprises Limited An improved process for the preparation of vortioxetine and salts thereof
CN112125868B (zh) * 2020-09-25 2021-08-03 中山万远新药研发有限公司 一种氢溴酸伏硫西汀晶型及其制备方法、组合物与用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA81749C2 (uk) * 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну
EP2439201B1 (en) * 2006-06-16 2013-08-07 H. Lundbeck A/S Compounds with combined sert, 5-ht3 and 5-ht1a activity
TW200848411A (en) * 2007-03-20 2008-12-16 Lundbeck & Co As H Novel therapeutic uses of 1-[2-(2, 4-dimethylphenylsulfanyl)phenyl]-piperazine
TW201033181A (en) * 2009-02-17 2010-09-16 Lundbeck & Co As H Purification of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine
CN104797566B (zh) 2012-09-19 2017-07-07 桑多斯股份公司 沃替西汀氢溴酸盐的新结晶形式
EP3099669A1 (en) * 2014-01-31 2016-12-07 Egis Gyógyszergyár Zrt. Process for the preparation of vortioxetine salts
US9687484B2 (en) 2014-07-18 2017-06-27 Dipharma Francis S.R.L. Crystalline forms of an antidepressant compound
CN105367515B (zh) 2015-05-08 2017-10-27 北京北陆药业股份有限公司 一种氢溴酸沃替西汀α晶型的制备方法
CN104910099B (zh) 2015-05-22 2017-03-08 扬子江药业集团有限公司 一种氢溴酸沃替西汀晶体的制备方法
CN106316986B (zh) 2015-07-03 2019-02-05 成都弘达药业有限公司 一种1-[2-(2,4-二甲基苯基硫烷基)苯基]哌嗪氢溴酸盐α型晶体的制备方法

Also Published As

Publication number Publication date
HUE057993T2 (hu) 2022-06-28
CL2019003024A1 (es) 2020-02-21
IL270052B2 (en) 2023-12-01
SMT202200073T1 (it) 2022-03-21
ES2905962T3 (es) 2022-04-12
CA3059515A1 (en) 2018-11-01
KR102551433B1 (ko) 2023-07-04
RU2019133770A (ru) 2021-05-25
DK3615518T3 (da) 2022-02-07
IL270052A (es) 2019-12-31
RU2019133770A3 (es) 2021-08-27
EP3615518A1 (en) 2020-03-04
US11124491B2 (en) 2021-09-21
EP3615518B1 (en) 2021-12-15
IL270052B1 (en) 2023-08-01
ZA201906829B (en) 2022-03-30
PT3615518T (pt) 2022-02-14
CY1124974T1 (el) 2023-01-05
SG11201909678PA (en) 2019-11-28
MA49056A (fr) 2020-03-04
SI3615518T1 (sl) 2022-02-28
LT3615518T (lt) 2022-03-10
JP7121751B2 (ja) 2022-08-18
US20200165217A1 (en) 2020-05-28
JP2020517674A (ja) 2020-06-18
HRP20220108T1 (hr) 2022-04-15
CN110520415A (zh) 2019-11-29
KR20190141155A (ko) 2019-12-23
AU2018258947C1 (en) 2021-08-26
PL3615518T3 (pl) 2022-03-07
AU2018258947A1 (en) 2019-10-31
AU2018258947B2 (en) 2021-02-25
RS62823B1 (sr) 2022-02-28
BR112018076411A2 (pt) 2019-04-09
WO2018197360A1 (en) 2018-11-01
MX2019012765A (es) 2019-12-05

Similar Documents

Publication Publication Date Title
HUE057926T2 (hu) Eljárás tiokarbonátok elõállítására
PL3519420T4 (pl) Cykliczne związki dinukleotydowe
PH12016502177A1 (en) Processes of preparing a jak1 inhibitor and new forms thereto
HUE046350T2 (hu) Eljárás aldehidek rugalmas elõállítására
GR20140100479A (el) Συνθεση λιραγλουτιδης
EP3400472A4 (en) DYNAMIC FRESNEL PROJECTOR
HUE052352T2 (hu) Eljárás propilén-oxid elõállítására
CL2020003254A1 (es) Procedimiento para la deshidratación de agua fangosa acuosa
EP3469251A4 (en) PUNCTUAL SOURCE OF INTEGRATION FOR TEXTURE PROJECTION BULB
IL284374A (en) Methods of producing ustekinumab
CO2019011592A2 (es) Proceso para la fabricación de la forma alfa de vortioxetina hbr
CL2021000902A1 (es) Método para la fabricación de gemas sintéticas.
IT201800011142A1 (it) Forma per la produzione di calzature
MX382659B (es) Proceso para la preparación de derivados de tiazol.
CL2017000645A1 (es) Síntesis de ent-progesterona e intermediarios de la misma
HUE064895T2 (hu) Eljárás palbociklib elõállítására
MX383694B (es) Proceso para la conversión directa de diisobuteno a un ácido carboxílico.
MX2019003584A (es) Proceso para la preparacion de la forma i de anhidrato de boscalid y la forma ii de anhidrato de boscalid.
IT201600127907A1 (it) Mescola per la produzione di suole per calzature
MX2016016398A (es) Preparacion de piperidin-4-carbotioamida.
TWD180363S (zh) 水龍頭
EP3722718A4 (en) BRICK COATING PROCESS
CL2017001466A1 (es) Un proceso para la fabricación de idalopirdina
AU367132S (en) Footwear
ES1232899Y (es) Calzado femenino